|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Stock Option (Right to Buy) | $ 4.86 | 12/02/2013 | M | 19,035 | (6) | 12/09/2015 | Common Stock | 19,035 | $ 0 | 0 | D | ||||
Stock Option (Right to Buy) | $ 18.75 | 12/02/2013 | M | 3,810 | (7) | 05/08/2018 | Common Stock | 3,810 | $ 0 | 0 | D | ||||
Stock Option (Right to Buy) | $ 7.06 | 12/02/2013 | M | 8,000 | (8) | 07/30/2019 | Common Stock | 8,000 | $ 0 | 0 | D | ||||
Stock Option (Right to Buy) | $ 14.48 | 12/02/2013 | M | 4,000 | (8) | 06/01/2020 | Common Stock | 4,000 | $ 0 | 0 | D | ||||
Employee Stock Option (Right to Buy) | $ 15.82 | 12/02/2013 | M | 27,363 | (9) | 01/10/2021 | Common Stock | 27,363 | $ 0 | 122,637 | D | ||||
Employee Stock Option (Right to Buy) | $ 15.82 | 12/03/2013 | M | 1,600 | (9) | 01/10/2021 | Common Stock | 1,600 | $ 0 | 121,037 | D |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
LIAMOS CHARLES T C/O INSULET CORPORATION 9 OAK PARK DRIVE BEDFORD, MA 01730 |
X | Chief Operating Officer |
/s/ R. Anthony Diehl, attorney in fact | 12/03/2013 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | Includes 33,334 restricted stock units granted on January 10, 2011 which vest on December 31, 2013; 24,000 restricted stock units granted on April 1, 2012 which vest one-third of the total units on April 1, 2014, one-third of the total units on April 1, 2015 and one-third of the total units on April 1, 2016; and 30,000 restricted stock units granted on March 1, 2013 which vest one-quarter of the total units on March 1, 2014, one-quarter of the total units on March 1, 2015, one-quarter of the total units on March 1, 2016 and one-quarter of the total units on March 1, 2017. Vested shares will be delivered to the reporting person as soon as practicable following avesting date. |
(2) | Includes an aggregate of 960 shares acquired under the Insulet Corporation Amended and Restated 2007 Employee Stock Purchase Plan on the following dates: 357 shares acquired on June 29, 2012; 360 shares acquired on December 31, 2012; and 243 shares acquired on June 28, 2013. |
(3) | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2013. |
(4) | The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $35.93 to $37.07. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full informaiton regarding the number of shares sold at each separate price. |
(5) | The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $35.97 to $36.01. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full informaiton regarding the number of shares sold at each separate price. |
(6) | This option is subject to a three-year vesting period, with 50% of the total award vesting one year after the grant date, 25% of the total award vesting two years after the grant date and 25% of the total award vesting three years after the grant date, subject to continued service as a director or consultant. |
(7) | This option is subject to a three-year vesting period with 50% of the total award vesting one year after the grant date, 25% of the total award vesting two years after the grant date and 25% of the total award vesting three years after the grant date, subject to continued service as a director or consultant. |
(8) | This option is subject to a three-year vesting period with 50% of the total award vesting on the first anniversary of the date of grant and 25% on each of the second and third anniversaries of the date of grant, subject to continued service as a director or consultant. |
(9) | This option is subject to a four-year vesting period, with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment. |